1.
Frantellizzi V, Pani A, Ippoliti MD, Farcomeni A, Aloise I, Colosi M, et al. Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in mCRPC patients candidates to 223RaCl treatment. Radiol Oncol [Internet]. 2020 Mar. 25 [cited 2026 Jun. 17];54(1):40-7. Available from: https://www.radioloncol.com/index.php/ro/article/view/3297